Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Published in: Cardiovascular Drugs and Therapy 4/1998

01-09-1998

Randomized, Double-Blind Placebo-Controlled Trial of Coenzyme Q10 in Patients with Acute Myocardial Infarction

Authors: Ram B. Singh, Gurpreet S. Wander, Amit Rastogi, Pradeep K. Shukla, Adarsh Mittal, Jagdish P. Sharma, Shiv K. Mehrotra, Raj Kapoor, Raj K. Chopra

Published in: Cardiovascular Drugs and Therapy | Issue 4/1998

Login to get access
Metadata
Title
Randomized, Double-Blind Placebo-Controlled Trial of Coenzyme Q10 in Patients with Acute Myocardial Infarction
Authors
Ram B. Singh
Gurpreet S. Wander
Amit Rastogi
Pradeep K. Shukla
Adarsh Mittal
Jagdish P. Sharma
Shiv K. Mehrotra
Raj Kapoor
Raj K. Chopra
Publication date
01-09-1998
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 4/1998
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1023/A:1007764616025

Other articles of this Issue 4/1998

Cardiovascular Drugs and Therapy 4/1998 Go to the issue

OriginalPaper

Effect of the β1-Blocker/β2-Agonist Celiprolol on Atrial Natriuretic Peptide Plasma Levels in Hypertensive Patients

OriginalPaper

Time Window for the Contribution of the δ-opioid Receptor to Cardioprotection by Ischemic Preconditioning in the Rat Heart

OriginalPaper

Treatment Challenges in Hypercholesterolemia

OriginalPaper

Observations on the Effect of Glibenclamide on Noninvasive Clinical Parameters of Myocardial Ischemia

OriginalPaper

Cytoprotection against Oxidative Stress in Rat Isolated Cardiomyocytes: Effect of EUK 8, a Nonprotein Catalytic Antioxidant

OriginalPaper

Temporal Pattern of the Effect of Verapamil on Myocardial Reinfarction

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits